Mesa Laboratories (MLAB) Current Deferred Revenue: 2014-2025
Historic Current Deferred Revenue for Mesa Laboratories (MLAB) over the last 12 years, with Mar 2025 value amounting to $14.8 million.
- Mesa Laboratories' Current Deferred Revenue fell 1.73% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 1.73%. This contributed to the annual value of $14.8 million for FY2025, which is 5.63% down from last year.
- Latest data reveals that Mesa Laboratories reported Current Deferred Revenue of $14.8 million as of FY2025, which was down 5.63% from $15.7 million recorded in FY2024.
- Mesa Laboratories' Current Deferred Revenue's 5-year high stood at $16.1 million during FY2023, with a 5-year trough of $9.0 million in FY2021.
- Moreover, its 3-year median value for Current Deferred Revenue was $15.7 million (2024), whereas its average is $15.5 million.
- Per our database at Business Quant, Mesa Laboratories' Current Deferred Revenue skyrocketed by 67.55% in 2022 and then decreased by 5.63% in 2025.
- Over the past 5 years, Mesa Laboratories' Current Deferred Revenue (Yearly) stood at $9.0 million in 2021, then spiked by 67.55% to $15.1 million in 2022, then increased by 6.83% to $16.1 million in 2023, then dropped by 2.56% to $15.7 million in 2024, then declined by 5.63% to $14.8 million in 2025.